Evaxion wins FDA fast-track status
Evaxion Biotech, a Danish biotech company, has received the US Food and Drug Administration’s (FDA) fast-track designation for EVX-01, a personalized cancer therapy candidate.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.